The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes

被引:83
作者
Egesten, Arne
Eliasson, Mette
Johansson, Helena M.
Olin, Anders I.
Morgelin, Matthias
Mueller, Anja
Pease, James E.
Frick, Inga-Maria
Bjorck, Lars
机构
[1] Lund Univ, Dept Clin Sci, Sect Resp Med, SE-22184 Lund, Sweden
[2] Lund Univ, Dept Clin Sci, Sect Clin & Expt Infect Med, SE-22184 Lund, Sweden
[3] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Leukocyte Biol Sect, London, England
关键词
D O I
10.1086/510857
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Pharyngitis caused by Streptococcus pyogenes is one of the most common bacterial infections in humans and is also a starting point for invasive S. pyogenes infection. Here, we describe that tonsil fluid from patients with streptococcal pharyngitis contains high amounts of the interferon ( IFN)-dependent CXC chemokine known as monokine induced by IFN-gamma ( MIG)/CXCL9. Also in vitro, inflamed pharyngeal epithelium produced large amounts of MIG/CXCL9 in the presence of bacteria. The CXC chemokines MIG/CXCL9, IFN-inducible protein-10/CXCL10, and IFN-inducible T cell alpha-chemoattractant/CXCL11 all showed antibacterial activity against S. pyogenes, and inhibition of MIG/CXCL9 expression reduced the antibacterial activity at the surface of inflamed pharyngeal cells. S. pyogenes of the clinically important M1 serotype secrets the protein streptococcal inhibitor of complement ( SIC), which inhibited the antibacterial activity of the chemokines. As exemplified by S. pyogenes pharyngitis, the data identify a novel innate defense mechanism against invasive bacteria on epithelial surfaces.
引用
收藏
页码:684 / 693
页数:10
相关论文
共 35 条
[1]
Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function [J].
Akesson, P ;
Sjoholm, AG ;
Bjorck, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :1081-1088
[2]
Antimicrobial activities of heparin-binding peptides [J].
Andersson, E ;
Rydengård, V ;
Sonesson, A ;
Mörgelin, M ;
Björck, L ;
Schmidtchen, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (06) :1219-1226
[3]
Review: The physiology of saliva and transfer of drugs into saliva [J].
Aps, JKM ;
Martens, LC .
FORENSIC SCIENCE INTERNATIONAL, 2005, 150 (2-3) :119-131
[4]
SMALL COLLOIDAL GOLD CONJUGATED TO FAB FRAGMENTS OR TO IMMUNOGLOBULIN-G AS HIGH-RESOLUTION LABELS FOR ELECTRON-MICROSCOPY - A TECHNICAL OVERVIEW [J].
BASCHONG, W ;
WRIGLEY, NG .
JOURNAL OF ELECTRON MICROSCOPY TECHNIQUE, 1990, 14 (04) :313-323
[5]
The CXCR3 binding chemokine IP-10/CXCL10: Structure and receptor interactions [J].
Booth, V ;
Keizer, DW ;
Kamphuis, MB ;
Clark-Lewis, I ;
Sykes, BD .
BIOCHEMISTRY, 2002, 41 (33) :10418-10425
[6]
NMR structure of CXCR3 binding chemokine CXCL11 (ITAC) [J].
Booth, V ;
Clark-Lewis, I ;
Sykes, BD .
PROTEIN SCIENCE, 2004, 13 (08) :2022-2028
[7]
CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10) [J].
Campanella, GSV ;
Lee, EMJ ;
Sun, J ;
Luster, AD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) :17066-17074
[8]
Cutting edge:: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity [J].
Cole, AM ;
Ganz, T ;
Liese, AM ;
Burdick, MD ;
Liu, L ;
Strieter, RM .
JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :623-627
[9]
Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 [J].
Cole, KE ;
Strick, CA ;
Paradis, TJ ;
Ogborne, KT ;
Loetscher, M ;
Gladue, RP ;
Lin, W ;
Boyd, JG ;
Moser, B ;
Wood, DE ;
Sahagan, BG ;
Neote, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) :2009-2021
[10]
Pathogenesis of group A streptococcal infections [J].
Cunningham, MW .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (03) :470-+